by admin | Aug 15, 2019 | Funding
Halodoc, an online healthcare platform based in Indonesia, has secured additional funding from strategic investors including the Bill & Melinda Gates Foundation, Allianz X and Prudential. Allianz and Prudential provide insurance services in Indonesia and are users...
by admin | Aug 14, 2019 | CE mark
ExThera Medical Corporation (ExThera) announced today that it has received CE Mark approval for its Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100) for the reduction of pathogens during bloodstream infections (BSI). This CE Mark signifies that Seraph 100...
by admin | Aug 13, 2019 | Licensing
Novartis AG’s small molecule phosphoinositide 3-kinase delta (PI3Kẟ) blocker CDZ173, which is in a registration-enabling study, is expected to reach the market in 2022 lastest. Activated Phosphoinositide 3-kinase Delta Syndrome (APDS) is an ultra-rare, debilitating...
by admin | Aug 12, 2019 | Funding
Glycomine, Inc., a biotechnology company focused on developing new therapies for rare diseases, today announced that it has raised $33 million in a Series B financing led by Novo Holdings A/S. Proceeds from the financing will be used to advance Glycomine’s...
by admin | Aug 11, 2019 | FDA
Binx Health, the pioneer in anywhere, anytime testing for women’s health, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its first-of-kind, highly sensitive and specific, molecular point-of-care...
